94 related articles for article (PubMed ID: 1329227)
1. Teniposide in the treatment of small cell lung cancer: a review.
Hansen HH; Dombernowsky P; Hansen M; Bork E
Semin Oncol; 1992 Apr; 19(2 Suppl 6):65-8. PubMed ID: 1329227
[TBL] [Abstract][Full Text] [Related]
2. Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma: a Phase II study of the Southwest Oncology Group.
Grozea PN; Crowley JJ; Canfield VA; Kingsbury L; Ross SW; Beltran GS; Laufman LR; Weiss GR; Livingston RB
Cancer; 1997 Sep; 80(6):1029-33. PubMed ID: 9305702
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of teniposide in small cell carcinoma of the lung.
Pedersen AG; Bork E; Osterlind K; Dombernowsky P; Hansen HH
Cancer Treat Rep; 1984 Oct; 68(10):1289-91. PubMed ID: 6098366
[TBL] [Abstract][Full Text] [Related]
4. [Teniposide and cisplatin compared with etoposide and cisplatin for treatment of small cell lung cancer].
Fan Y; Huang ZY; Zhang YP; Sun L
Ai Zheng; 2002 Dec; 21(12):1368-71. PubMed ID: 12520751
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinoma.
Hainsworth JD; Stroup SL; Greco FA
Cancer; 1996 Jun; 77(12):2458-63. PubMed ID: 8640693
[TBL] [Abstract][Full Text] [Related]
6. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S
Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel, carboplatin, and oral etoposide in the treatment of small cell lung cancer.
Greco FA; Hainsworth JD
Semin Oncol; 1996 Dec; 23(6 Suppl 16):7-10. PubMed ID: 9007113
[TBL] [Abstract][Full Text] [Related]
8. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA
Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
[TBL] [Abstract][Full Text] [Related]
9. Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: a phase II trial of the North Central Cancer Treatment Group.
Jett JR; Hatfield AK; Hillman S; Bauman MD; Mailliard JA; Kugler JW; Morton RF; Marks RS; Levitt R
Cancer; 2003 May; 97(10):2498-503. PubMed ID: 12733149
[TBL] [Abstract][Full Text] [Related]
10. The European Organization for Research and Treatment of Cancer experience with teniposide: preliminary results of a randomized study in non-small cell lung cancer.
Giaccone G; Splinter TA; Kirkpatrick A; Dalesio O; van Zandwijk N; McVie JG
Semin Oncol; 1992 Apr; 19(2 Suppl 6):98-102. PubMed ID: 1329231
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
Lee YC; McCrystal MR; Christmas TI
N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing response to second-line treatment with teniposide (VM26) in patients with progressive small cell lung cancer (SCLC).
Tummarello D; Graziano F; Giordani P; Cellerino R
Anticancer Res; 1993; 13(4):1055-8. PubMed ID: 8394668
[TBL] [Abstract][Full Text] [Related]
13. A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.
Mok TS; Wong H; Zee B; Yu KH; Leung TW; Lee TW; Yim A; Chan AT; Yeo W; Chak K; Johnson P
Cancer; 2002 Oct; 95(7):1511-9. PubMed ID: 12237920
[TBL] [Abstract][Full Text] [Related]
14. Teniposide (VM26) as second-line treatment for small cell lung cancer.
Tummarello D; Guidi F; Torresi U; Dazzi C; Cellerino R
Anticancer Res; 1990; 10(2A):397-9. PubMed ID: 2161198
[TBL] [Abstract][Full Text] [Related]
15. Randomized phase II study of daily versus continuous-infusion schedules of topotecan in the treatment of extensive-stage small cell lung cancers.
Schaefer PL; Marks RS; Mahoney MR; Sloan JA; Bauman MD; Tazelaar HD; Kugler JW; Mailliard JA; Ebbert LP; Wiesenfeld M
Am J Clin Oncol; 2003 Jun; 26(3):236-40. PubMed ID: 12796591
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of 2 cisplatin and etoposide dosages in relapsing small cell lung cancer].
Trillet-Lenoir V; Lasset C; Arpin D; Bohas C; Riou R; Perol M; Fournel P; Rebattu P; Caillet B; Pacheco Y
Bull Cancer; 1992; 79(12):1173-81. PubMed ID: 1339011
[TBL] [Abstract][Full Text] [Related]
17. A phase I trial of carboplatin and etoposide for elderly (>or=75 year-old) patients with small-cell lung cancer.
Fukuda M; Soda H; Soejima Y; Fukuda M; Kinoshita A; Takatani H; Kasai T; Nagashima S; Kawabata S; Doi S; Kohno S; Oka M
Cancer Chemother Pharmacol; 2006 Nov; 58(5):601-6. PubMed ID: 16463061
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Morrissey LH; Scullin DC; Houston GA; Prasthofer EF; Gray JR; Burris HA; Greco FA
Cancer; 2002 May; 94(9):2426-33. PubMed ID: 12033195
[TBL] [Abstract][Full Text] [Related]
19. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel-based three-drug combinations for the treatment of small cell lung cancer: a review of the Sarah Cannon Cancer Center experience.
Hainsworth JD; Burris HA; Greco FA
Semin Oncol; 2001 Apr; 28(2 Suppl 4):43-7. PubMed ID: 11479897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
